In this same study, discordant mutations in KRAS/NRAS and BRAF were not observed; the only private mutations, defined as mutations seen only in the primary or metastatic tumor, were seen at the level of the APC, PIK3CA, SMAD4 and TP53 genes. This evidence concerns the gene NRAS and metastatic neoplasm.